P19 embryonal carcinoma cells exhibit high sensitivity to botulinum type C and D/C mosaic neurotoxins.
about
CRISPR/Cas9-Mediated Genomic Deletion of the Beta-1, 4 N-acetylgalactosaminyltransferase 1 Gene in Murine P19 Embryonal Carcinoma Cells Results in Low Sensitivity to Botulinum Neurotoxin Type C.Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discoveryProgress in cell based assays for botulinum neurotoxin detectionBotulinum protease-cleaved SNARE fragments induce cytotoxicity in neuroblastoma cells.
P2860
P19 embryonal carcinoma cells exhibit high sensitivity to botulinum type C and D/C mosaic neurotoxins.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
P19 embryonal carcinoma cells ...... C and D/C mosaic neurotoxins.
@en
P19 embryonal carcinoma cells ...... C and D/C mosaic neurotoxins.
@nl
type
label
P19 embryonal carcinoma cells ...... C and D/C mosaic neurotoxins.
@en
P19 embryonal carcinoma cells ...... C and D/C mosaic neurotoxins.
@nl
prefLabel
P19 embryonal carcinoma cells ...... C and D/C mosaic neurotoxins.
@en
P19 embryonal carcinoma cells ...... C and D/C mosaic neurotoxins.
@nl
P2093
P2860
P1476
P19 embryonal carcinoma cells ...... C and D/C mosaic neurotoxins.
@en
P2093
Hideyuki Arimitsu
Keiji Nakamura
Kentaro Tsukamoto
Koki Taniguchi
Nipawan Nuemket
Sadayuki Ochi
Shunji Kozaki
Takao Tsuji
Yoshikazu Tanaka
P2860
P304
P356
10.1111/J.1348-0421.2012.00490.X
P577
2012-10-01T00:00:00Z